Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Persistence and Re-vaccination with Menactra or Menomune in Adults
NCT01239043Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2010
- Primary completion
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal A conjugate vaccine, quadrivalent meningococcal polysaccharide vaccine in meningococcal infection, sponsored by Sanofi. Started Nov 2010; status: completed.
02
Drugs
meningococcal A conjugate vaccinequadrivalent meningococcal polysaccharide vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT01239043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239043.